Clinical Trial Update: A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study [Phase 3]

View source ↗

Summary

This update reports long-term follow-up data from AbbVie’s hepatitis C trial participants, comparing outcomes based on whether they achieved sustained virologic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2017-11-06